These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study. Seçkin İ; Uzunalan M; Pekpak M; Köktürk S; Sönmez HA; Güngör ZB; Demirkiran ÖD; Saygi Hİ; Yaprak Saraç E Rom J Morphol Embryol; 2017; 58(3):823-830. PubMed ID: 29250660 [TBL] [Abstract][Full Text] [Related]
68. Puromycin aminonucleoside nephrosis in rats: a progress report of acute and chronic experiments. LANNIGAN R Guys Hosp Rep; 1962; 111():378-87. PubMed ID: 13928692 [No Abstract] [Full Text] [Related]
69. Study of some serum and urinary proteins during Masugi nephritis in the rat. Versavel C; Dudragne D; Lebreton De Vonne T; Mouray H Comp Biochem Physiol A Comp Physiol; 1976; 55(3):231-6. PubMed ID: 9230 [No Abstract] [Full Text] [Related]
70. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Diamond JR; Pesek I Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206 [TBL] [Abstract][Full Text] [Related]
71. Cytotoxicity of sera from rats with puromycin aminonucleoside nephrosis. Natori Y; Igawa Y; Nakao N; Natori Y Nephron; 1996; 73(2):258-63. PubMed ID: 8773353 [TBL] [Abstract][Full Text] [Related]
72. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis. Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424 [TBL] [Abstract][Full Text] [Related]
73. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Ebihara I; Nakamura T; Tomino Y; Koide H Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058 [TBL] [Abstract][Full Text] [Related]
74. The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune-deposit formation in passive Heymann nephritis. Couser WG; Salant DJ; Stilmant MM; Arbeit LA; Darby C; Sliogeris VG J Lab Clin Med; 1979 Dec; 94(6):917-32. PubMed ID: 501213 [No Abstract] [Full Text] [Related]
75. Studies on the elastase-serum protein interaction. I. Molecular identity of the inhibitors in human serum and direct demonstration of inhibitor-elastase complexes by zone and immunoelectrophoresis. Baumstark JS Arch Biochem Biophys; 1967 Mar; 118(3):619-30. PubMed ID: 4167390 [No Abstract] [Full Text] [Related]
76. [Rabbit alpha macroglobulins during experimental nephrosis]. Lebreton de Vonne T; Mouray H Comp Biochem Physiol A Comp Physiol; 1975 Feb; 50(2):315-8. PubMed ID: 234338 [No Abstract] [Full Text] [Related]
77. Variants of normal human alpha2-macroglobulin. Immunoelectrophoresis and enzyme-binding effect. Gallango ML; Castillo O Humangenetik; 1975; 26(1):71-4. PubMed ID: 50267 [TBL] [Abstract][Full Text] [Related]